THE SHORT ANSWER
High-Performance Science Teams™ helps CDMO site and program teams, process development, MSAT, manufacturing, QA, QC, and client program management, work as one team across the handoffs where biomanufacturing programs slip. It targets the behaviors behind rocky tech transfers, repeat deviations closed as “human error,” and clients who hear different answers from different functions.
Why do CDMO programs slip when the process is sound?
Ask a CDMO site head where a program went sideways, and the answer is rarely the bioreactor. It’s the handoff: process development transferring a package MSAT didn’t help write, manufacturing receiving a batch record that doesn’t match, QA discovering a gap during review instead of during design, and the client program manager relaying a schedule change no one agreed on internally.
Each function is usually competent in isolation. The failure happens between them, and in a contract manufacturing business, the client experiences every internal seam.
What does team dysfunction look like on a CDMO site?
- Tech transfer over the wall. Process development hands over a package; MSAT inherits unanswered scale-up questions; the engineering run becomes the discovery phase.
- QA versus operations. Quality is experienced as the department that says no, so operations routes around it until review — and batch disposition slows down.
- Deviations closed as “human error.” “Human error” remains one of the most commonly cited deviation root causes, and quality leaders increasingly argue it often masks deeper system and communication problems. Retraining is assigned; the underlying handoff stays broken.
- Change control bottlenecks. Every function has a veto and no one owns the decision timeline.
- Shift and handover gaps. Critical context lives in individuals, not in team agreements.
- Many voices to the client. The program manager, site head, and QA lead give the client different versions of the same schedule or investigation status.
Why don’t MES, reorganizations, or more training fix it?
CDMOs reach for vertical fixes: a new MES or electronic batch record system, a reorganized MSAT function, another round of GMP retraining. These are often necessary. But an electronic batch record digitizes the handoff; it doesn’t make process development and manufacturing agree on it. Retraining addresses the individual; the deviation came from the system between individuals.
It is a horizontal problem, performance across functions, and it needs a horizontal fix.
How does High-Performance Science Teams™ work for biomanufacturing teams?
The program applies Guttman Development Strategies’ horizontal high-performance team model to site leadership teams and client program teams, working on live programs, live investigations, and live client commitments.
| Site pattern | Root behavior | What HPT installs |
| Rocky tech transfer and engineering runs | Handoffs owned by the sender, not both sides | Joint PD–MSAT–manufacturing accountability for transfer readiness |
| QA–operations friction | Quality seen as a gate, not a teammate | QA seated in program decisions early, with an explicit protocol for disagreement |
| Repeat “human error” deviations | Investigations stop at the individual | Team norms for surfacing system and handoff causes during CAPA |
| Change control delays | Vetoes without decision ownership | A decision charter with named owners and timelines |
| Inconsistent client messages | No single internal position | Align-before-you-speak protocol so the client hears one answer |
How does this fit a CDMO’s commercial motion?
CDMOs win repeat business on reliability, and reliability is a team behavior. Many CDMOs pair two motions: High-Performance Science Teams™ for site, technical, and quality teams, and Bench to Business™ for the BD leads, program managers, and technical account managers who carry the client relationship.
Who is it for?
Site heads, VPs of Operations, Heads of Quality, MSAT and process development leaders, program management leaders, and CHROs at biologics, cell and gene therapy, viral vector, and small-molecule CDMOs — especially sites scaling headcount quickly or onboarding new client programs.
How do we get started?
Start with the Science Team 360™ a short, confidential team-level diagnostic that shows exactly where decision rights, alignment, and accountability are breaking down inside your site or program team. You get a readout before anyone commits to a full engagement.
Request a Science Team 360™ conversation at bench2business.bio.
Frequently asked questions
What causes delays in CDMO tech transfer?
Beyond technical scale-up issues, tech transfer delays usually come from handoffs owned by one side: process development packages written without MSAT and manufacturing input, late QA involvement, and unclear decision ownership for changes.
How can a CDMO improve right-first-time performance?
By treating right-first-time as a cross-functional outcome: aligning PD, MSAT, manufacturing, and QA on shared goals, clarifying decision rights, and investigating deviations for system and handoff causes rather than stopping at individual error.
Does High-Performance Science Teams™ replace quality systems or GMP training?
No. It works alongside your QMS and training programs, improving how teams collaborate, escalate, and investigate within them.
How does team performance affect the CDMO client experience?
Clients experience every internal seam. Teams that align before communicating give the client one consistent answer on schedules, investigations, and risks — which builds the trust behind repeat business.
How do we start?
With the Science Team 360™, a confidential diagnostic of your site or program team that pinpoints where alignment and accountability break down.
Sources
- GEN — Genetic Engineering & Biotechnology News, “Blaming Just Human Error Can Mask Deeper Bioprocess Problems” — https://www.genengnews.com/topics/bioprocessing/biopharma-must-do-more-to-understand-deviations/
- BioProcess Online, “‘Human Error’ Deviations: Why You Should Stop Creating (Most Of) Them” — https://www.bioprocessonline.com/doc/human-error-deviations-why-you-should-stop-creating-most-of-them-0001
- Guttman, H.M. Great Business Teams: Cracking the Code for Standout Performance (Wiley, 2008) — https://www.guttmandev.com/great-business-teams
Figures from third-party studies are cited as published. Cross-industry data is presented as directional for life science. Program outcomes described are targets teams track against their own Science Team 360™ baseline, not guaranteed results.